AbbVie

Open: 140.0 Close: 138.67 Change: -1.33

You don't have read the whole internet to decide whether to invest in AbbVie. Use an AI.

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, Abbvie, Futures, ABBV, stock, result, and the most common words in the summary are: abbvie, stock, market, job, news, price, company, . One of the sentences in the summary was: Upadadacinib has a market cap of $244.82 billion.. Other searches related to this term …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo. Upadadacinib has a market cap of $244.82 billion.

Today's News

AbbVie Inc. per Employee $1.103M P/E Ratio 37.95E: $3.65 Yield 4.47% Dividend $1.55 Ex-Dividend Date Jan 12, 2024 Short Interest 13.23M 10/31/23. AbbVie reports financial results for the third quarter ended September 30, 2023. Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo. AbbVie accuses Sandoz, Hetero Labs, Aurobindo Pharma, Intas Pharmaceuticals and Sun Pharmaceutical of trying to sidestep dozens of patents protecting Rinvoq through the next decade. Alongside its sister medicine Skyrizi, Abbvie expects Rinvie to form a bulwark. AbbVie Inc. (ABBV) stock price, quote, news & analysis. Share your opinion in the form of your opinion. AbbVie Inc. markets closed S&P Futures 4,555.00 -13.25 (-13.00%) Dow Futures 35,346.00 (-84.00) Nasdaq Futures 15,948.75 -72.25 (0.45%) Russell 2000 Futures 1,803.40 (-1.60) Crude Oil 74.80 +8; DAFTR Charleston Farmer publisheddose Ny reliably Bore Slay video model capt Rein The company cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those indicated in the forward-statements. We will provide combined AbbVie and Allergan guidance after the close of the planned transaction. Pharmaceutical majors AbbVie (ABBV.N) and Eli Lilly (LLY.N.) in January withdrew from the scheme. Abbvie has a market cap of $244.82 Billion. AbbVie has more than 1,200,000 employees. Explore our open positions at www.abbvie.com. Manufacturing Operator III, UD Fill, B1 Shift (7am - 7pm) Abbvie Waco, Texas Job Summary Perform production line duties required to meet production goals while complying with quality standards. AbbV - Abbvie Inc stock price and quote. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (Zacks) Could AbbBVie Stock Help You Become a Millionaire? (Motley Fool) AbbVie Inc (ABBV) stock is higher by 0.04% while the S&P 500 has fallen -0.04%. MorphoSys CEO has previously said Abbvie “failed” its phase 3 myelofibrosis trial because the Big Pharma missed one of two endpoints.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, Abbvie, Futures, ABBV, stock, result, and the most common words in the summary are: abbvie, stock, market, job, news, price, company, . One of the sentences in the summary was: Upadadacinib has a market cap of $244.82 billion.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #job #news #price #company.